Select all docs (Max 200)
Narrow Results:
Publication Year
- 2010 1
Medical Subject
- Adult 1
- Antifungal Agents 1
- Aspergillosis 1
- Aspergillus Fumigatus 1
- Fatal Outcome 1
- Glucocorticoids 1
- Humans 1
- Immunocompetence 1
- Influenza, Human 1
- Influenza A Virus, H1N1 Subtype 1
- Male 1
- Methylprednisolone 1
- Middle Aged 1
- Pandemics 1
- Respiratory Distress Syndrome, Adult 1
- Risk Factors 1
- Time Factors 1
Personal Author
Resource Type General
Emerg Infect Dis. 16(6):971-973.
Select all docs (Max 200)
1 Results
Refine Results
Refine Results:
- Adult (1)
- Antifungal Agents (1)
- Aspergillosis (1)
- Aspergillus Fumigatus (1)
- Fatal Outcome (1)
- Glucocorticoids (1)
- Humans (1)
- Immunocompetence (1)
- Influenza, Human (1)
- Influenza A Virus, H1N1 Subtype (1)
- Male (1)
- Methylprednisolone (1)
- Middle Aged (1)
- Pandemics (1)
- Respiratory Distress Syndrome, Adult (1)
- Risk Factors (1)
- Time Factors (1)
- :Lat, Asma ;Bhadelia, NahidJun 2010 | Emerg Infect Dis. 16(6):971-973.:We report 2 patients with invasive aspergillosis after infection with pandemic (H1N1) 2009. Influenza viruses are known to cause immunologic defects a...
To see more results, try removing search filters or changing the search terms
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.